ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
34 announcements with these filters
Metropolis Healthcare Ltd reported revenue from operations of ₹424.7 Cr (+23.0% YoY) and net profit of ₹51 Cr (+74.7% YoY) for Q4 FY26.
Metropolis Healthcare reported its financial results and declared an interim dividend totaling ₹20.73 Crore. The board also recommended Deloitte Haskins & Sells as new statutory auditors.
Metropolis Healthcare allotted 4,200 equity shares and granted 2,26,581 new stock benefits. The ₹0.00084 Crore allotment follows employee stock option exercises and RSU plan vesting.
Metropolis Healthcare Ltd has scheduled a Board Meeting for May 13, 2026. The board will consider audited FY26 financial results and the declaration of a second interim dividend for FY26. Consequently, the company's trading window remains closed until May 15, 2026.